SAN DIEGO, March 24, 2026 /PRNewswire/ — Starlight Cardiovascular announced that the first baby in the world was treated with its Lifeline™ Ductus Arteriosus Stent System at Cincinnati Children’s Hospital in January. The device is currently being studied under a U.S. Food and Drug Administration Investigational Device Exemption clinical trial.
Dr. Shabana Shahanavaz, a pediatric interventional cardiologist and Director of the Cardiac Catheterization Laboratory at Cincinnati Children’s Hospital, performed the procedure on an 8-day-old baby with Double Inlet Left Ventricle and Pulmonary Atresia, a complex congenital heart defect that results in inadequate blood flow to the baby’s lungs. Starlight’s Lifeline™ Stent is designed to keep the ductus arteriosus, a vessel that exists in the fetal circulation and closes shortly after birth, open to provide critical pulmonary blood flow.